by Darryl Inaba, William E. Cohen, Paul J. Steinbroner
First section focuses on psychedelics such MDMA ("ecstasy"), GHB and GBL (blue nitro"), LSD, psilocybin mushrooms, peyote, and ketamine. Second part concentrates on inhalants such as nitrous oxide, volatile solvents (glue, gasoline), and volatile nitrites. Examines the physiological and psychological affects on the drugs on memory, mood, and health consequences of long term use.
1946
Darryl S. Inaba (born June 16, 1946) is an American pharmacist who is the remaining owner and President of CNS Productions, Inc. in Medford, OR. He is an associate professor of Pharmacology at the UCSF Medical Center in San Francisco, California, and the Director of Clinical and Behavioral Health Services at ARC (Addiction Recovery Center) in Medford, Oregon. He is also special consultant and instructor for the University of Utah School of Alcoholism and Other Drug Dependencies, as well as the Director of Education and Research at CNS Productions.[1] Dr. Inaba is also on the editorial board of the Journal of Psychoactive Drugs, which has been published since 1967. -Wikipedia
1941
No reviews yet — be the first to write one from the Log screen.
No quotes yet.
